In addition, in our in vitro iPSC-CM model, the combination of ERT plus IL-18 neutralization effectively ameliorated and prevented the progression of hypertrophy and cardiomyopathy in hypertrophic FC-iPSC-CMs (Figure 8). The gene discussed is ELF3; the disease is cardiomyopathy.